Question

Which of the following ICH Harmonized Tripartite Guidelines related to stability, provides approaches that allows for bracketing and matrixing designs for stability testing. This is especially important when a new drug product is to be commercialized with multiple strengths in multiple packaging configurations.

• A. Q1F
• B. Q1D
• C. Q1B
• D. Q1A

Answer 1

The Correct Option is B

The question relates to the ICH Harmonized Tripartite Guidelines, specifically focusing on stability testing methodologies for new drug products that are to be commercialized with multiple strengths and packaging configurations. Let's discuss the options provided:

1. Q1A: This guideline primarily deals with stability testing of new drug substances and products. It sets the core stability testing requirements and is foundational, but it does not specifically address bracketing and matrixing designs.
2. Q1B : This guideline pertains to photostability testing, which is crucial for ensuring that a drug product does not degrade under light exposure. However, it is not related to bracketing and matrixing approaches.
3. Q1D: This guideline directly relates to bracketing and matrixing designs in stability testing. It provides the important approaches needed for drugs that will be produced in multiple strengths and packages, making it highly relevant to the question.
4. Q1F: This guideline provides insights for the evaluation of stability data but does not focus on the bracketing and matrixing methods specifically.

As our analysis shows, Q1D provides guidance on applying bracketing and matrixing designs for stability testing, which are essential when dealing with multiple strengths and packaging configurations of a new drug product. Therefore, the correct answer is Q1D.